|
1
|
Newell-Price J, Bertagna X, Grossman AB
and Nieman LK: Cushing's syndrome. Lancet. 367:1605–1617. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Colao A, Boscaro M, Ferone D and Casanueva
FF: Managing Cushing's disease: The state of the art. Endocrine.
47:9–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lindholm J, Juul S, Jørgensen JO, Astrup
J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jørgensen J, Kosteljanetz
M, Kristensen L, et al: Incidence and late prognosis of Cushing's
syndrome: A population-based study. J Clin Endocrinol Metab.
86:117–123. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nieman LK, Biller BM, Findling JW, Murad
MH, Newell-Price J, Savage MO and Tabarin A; Endocrine Society, :
Treatment of Cushing's Syndrome: An Endocrine Society Clinical
Practice Guideline. J Clin Endocrinol Metab. 100:2807–2831. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chanson P and Salenave S: Metabolic
syndrome in Cushing's syndrome. Neuroendocrinology. 92 Suppl
1:96–101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hassan-Smith ZK, Sherlock M, Reulen RC,
Arlt W, Ayuk J, Toogood AA, Cooper MS, Johnson AP and Stewart PM:
Outcome of Cushing's disease following transsphenoidal surgery in a
single center over 20 years. J Clin Endocrinol Metab. 97:1194–1201.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
American Diabetes Association, . 2.
Classification and Diagnosis of Diabetes: Standards of Medical Care
in Diabetes-2018. Diabetes Care. 41 Suppl 1:S13–S27. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alberti KG, Zimmet P and Shaw J: Metabolic
syndrome - a new world-wide definition. A Consensus Statement from
the International Diabetes Federation. Diabet Med. 23:469–480.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kai H: Blood pressure management in
patients with type 2 diabetes mellitus. Hypertens Res. 40:721–729.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Little RR and Rohlfing CL: The long and
winding road to optimal HbA1c measurement. Clin Chim Acta.
418:63–71. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iwayama H, Hirase S, Nomura Y, Ito T,
Morita H, Otake K, Okumura A and Takagi J: Spontaneous
adrenocorticotropic hormone (ACTH) normalisation due to tumour
regression induced by metyrapone in a patient with ectopic ACTH
syndrome: Case report and literature review. BMC Endocr Disord.
18:192018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kageyama K, Oki Y, Sakihara S, Nigawara T,
Terui K and Suda T: Evaluation of the diagnostic criteria for
Cushing's disease in Japan. Endocr J. 60:127–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Melmed S and Jameson JL:
HypopituitarismHarrison's Principles of Internal Medicine. 19th
edition. McGraw-Hill Education; New York, NY: pp. 2255–2261.
2015
|
|
14
|
Fukuda I, Hizuka N, Nuraoka T and Ichihara
A: Adult growth hormone deficiency: Current concepts. Neurol Med
Chir (Tokyo). 54:599–605. 2014. View Article : Google Scholar
|
|
15
|
Newell-Price J, Morris DG, Drake WM,
Korbonits M, Monson JP, Besser GM and Grossman AB: Optimal response
criteria for the human CRH test in the differential diagnosis of
ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab.
87:1640–1645. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pivonello R, De Martino MC, De Leo M,
Simeoli C and Colao A: Cushing's disease: The burden of illness.
Endocrine. 56:10–18. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pivonello R, De Leo M, Cozzolino A and
Colao A: The Treatment of Cushing's Disease. Endocr Rev.
36:385–486. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Geer EB, Shen W, Strohmayer E, Post KD and
Freda PU: Body composition and cardiovascular risk markers after
remission of Cushing's disease: A prospective study using
whole-body MRI. J Clin Endocrinol Metab. 97:1702–1711. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bouclaous C, Torbay N, Nassar C and Hwalla
N: Modification of glucocorticoid effects on body weight gain,
plasma lipids by changes in diet composition. Nutr Res.
23:1105–1115. 2003. View Article : Google Scholar
|
|
20
|
Tamez-Pérez HE, Quintanilla-Flores DL,
Rodríguez-Gutiérrez R, González-González JG and Tamez-Peña AL:
Steroid hyperglycemia: Prevalence, early detection and therapeutic
recommendations: A narrative review. World J Diabetes. 6:1073–1081.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sopjani M, Alesutan I, Wilmes J,
Dërmaku-Sopjani M, Lam RS, Koutsouki E, Jakupi M, Föller M and Lang
F: Stimulation of Na+/K+ ATPase activity and
Na+ coupled glucose transport by β-catenin. Biochem Biophys Res
Commun. 402:467–470. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hawley SA, Ford RJ, Smith BK, Gowans GJ,
Mancini SJ, Pitt RD, Day EA, Salt IP, Steinberg GR and Hardie DG:
The Na+/glucose cotransporter inhibitor canagliflozin
activates AMPK by inhibiting mitochondrial function and increasing
cellular AMP Levels. Diabetes. 65:2784–2794. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kola B, Christ-Crain M, Lolli F, Arnaldi
G, Giacchetti G, Boscaro M, Grossman AB and Korbonits M: Changes in
adenosine 5-monophosphate-activated protein kinase as a mechanism
of visceral obesity in Cushing's syndrome. J Clin Endocrinol Metab.
93:4969–4973. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kelly J, Hunt BJ, Lewis RR, Swaminathan R,
Moody A, Seed PT and Rudd A: Dehydration and venous thromboembolism
after acute stroke. QJM. 97:293–296. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yasui A, Lee G, Hirase T, Kaneko T,
Kaspers S, von Eynatten M and Okamura T: Empagliflozin induces
transient diuresis without changing long-term overall fluid balance
in Japanese patients with type 2 diabetes. Diabetes Ther.
9:863–871. 2018.PubMed/NCBI
|
|
26
|
Gelbenegger G, Buchtele N, Schoergenhofer
C, Roeggla M and Schwameis M: Severe hypernatraemic dehydration and
unconsciousness in a care-dependent inpatient treated with
empagliflozin. Drug Saf Case Rep. 4:172017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Andersen A, Lund A, Knop FK and Vilsbøll
T: Glucagon-like peptide 1 in health and disease. Nat Rev
Endocrinol. 14:390–403. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cuevas-Ramos D, Lim DST and Fleseriu M:
Update on medical treatment for Cushing's disease. Clin Diabetes
Endocrinol. 2:162016. View Article : Google Scholar : PubMed/NCBI
|
